Make an inquiry
Refer a patient
We noticed you are on our US page. Want to switch regions? Choose from the options:
UK
AU
ES
Find a location
Find a doctor
Make an inquiry
Refer a patient
We noticed you are on our US page. Want to switch regions? Choose from the options:
UK
AU
ES
Find a location
Find a doctor
Make an inquiry
Refer a patient
Healthcare Professionals
Latest research
Publications
A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients
20 Jan 2019
A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients.
Written by
Shore Neal D., MD, FACS
Mincik I, DeGuenther M, Student V Jr, Jievaltas M, Patockova J, Simpson K, Hu CH, Huang ST, Li Y, Lee Y, Chien B, Mao J.
Back to top